ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GLUE Monte Rosa Therapeutics Inc

5.74
0.24 (4.36%)
Last Updated: 13:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Monte Rosa Therapeutics Inc GLUE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 4.36% 5.74 13:00:00
Open Price Low Price High Price Close Price Prev Close
5.57 5.52 6.045 5.50
more quote information »

Recent News

Date Time Source Heading
3/14/202407:00GLOBEMonte Rosa Therapeutics Announces Fourth Quarter and Full..
3/11/202407:00GLOBEMonte Rosa Therapeutics Announces Initiation of IND Enabling..
1/31/202407:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
1/08/202407:47EDGAR2Form 8-K - Current report
1/08/202407:15GLOBEMonte Rosa Therapeutics Provides Corporate Update and Key..
1/04/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202407:00GLOBEMonte Rosa Therapeutics to Present at the 42nd Annual J.P...
11/21/202307:00GLOBEMonte Rosa Therapeutics to Present at Piper Sandler..
11/09/202307:27EDGAR2Form 8-K - Current report
11/09/202307:00GLOBEMonte Rosa Therapeutics Announces Third Quarter 2023..
11/07/202310:00GLOBEMonte Rosa Therapeutics Presents Preclinical Data at ACR..
10/27/202307:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
10/26/202317:01EDGAR2Form 8-K - Current report
10/26/202316:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/26/202316:30GLOBEMonte Rosa Therapeutics Announces $25 Million Registered..
10/17/202307:55EDGAR2Form 8-K - Current report
10/17/202307:00GLOBEMonte Rosa Therapeutics Announces Strategic Collaboration..
8/18/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/15/202317:16EDGAR2Form 144 - Report of proposed sale of securities
8/10/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:19EDGAR2Form 8-K - Current report
8/10/202307:15GLOBEMonte Rosa Therapeutics Announces Second Quarter 2023..
7/26/202307:53EDGAR2Form 8-K - Current report
7/26/202307:30GLOBEMonte Rosa Therapeutics Appoints Dr. Anthony M. Manning to..
5/30/202316:30GLOBEMonte Rosa Therapeutics to Present at Upcoming Investor and..
5/23/202307:30GLOBEMonte Rosa Therapeutics Advances Second Development..
5/11/202307:30GLOBEMonte Rosa Therapeutics Announces First Quarter 2023..

Your Recent History

Delayed Upgrade Clock